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Abstract
Background: Interleukin (IL)-1β is involved in the pathology of intervertebral disc degeneration. Under normal
conditions, IL-1β is present in cells in an inactive form (pro-IL-1β). However, under pathological conditions, pro-IL-1β
is turned into its active form (IL-1β) by the inflammasome, a multi-protein complex of the innate immune response
that activates caspase-1. Under conditions of degeneration, the disc experiences an environment of increased
acidification. However, the implications of acidification on the innate immune response remain poorly explored.
Methods: Here we have studied how pH changes in human nucleus pulposus cells affect inflammasome activation
by immunoblot analysis of protein lysates obtained from nucleus pulposus cells that were exposed to different pH
levels in culture.
Results: In this study, we have found that in nucleus pulposus cells, with increased acidification, there was a decrease
in inflammasome activation consistent with lower levels of active IL-1β. However, this effect at a pH of 6.5, the lowest
pH level tested, was abrogated when cells were treated with IL-1β.
Conclusions: Taken together, these findings suggest that the inflammatory response through IL-1β experienced by
the human disc is not initiated in nucleus pulposus cells when the stimulus is acidification.
Keywords: Innate Immunity, Intervertebral disc degeneration, Caspase-1, Inflammasome, Inflammation
Abbreviations: ALR, AIM-2-like receptor; ASC, Apoptosis-associated speck-like protein containing a caspase recruitment
domain; ATP, Adenosine tri-phosphate; ECM, Extracellular matrix; HNPC, Human nucleus pulposus cells;
IDD, Intervertebral disc degeneration; IL, Interleukin; IVD, Intervertebral disc; LDH, Lactose dehydrogenase;
LPS, Lipopolysaccharide; MMP, Matrix metalloproteinases; NLR, NOD-like receptor; TLR, Toll-like receptor; TNF, Tumor
necrosis factor; XIAP, X-linked inhibitor of apoptosis protein
Background
Low back pain is a major pathological condition that af-
fects approximately 84 % of the population at some
point in their life [1]. Estimates indicate that in the
United States, 25 % of the population suffers from low
back or neck pain [2]. Accordingly, the societal costs as-
sociated with low back and neck pain exceeds $100
billion per year in the United States alone [3]. Interverte-
bral disc (IVD) degeneration (IDD) is believed to be a
major contributor to back pain [4–7]. The etiology of
IDD has been linked to genetic factors, aging or exces-
sive manual labor [8]. All these factors contribute to in-
crease inflammation, which eventually leads to increased
degradation of aggrecan and collagen in the extracellular
matrix of the disc [9].
Historically most studies looking at inflammation have
focused on looking at professional immune cells as neu-
trophils and macrophages. However, recent studies indi-
cate that cells that are not professionally considered as
immune cells do play an important role on inflammation.
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This concept applies to cells as diverse as neurons
[10–13] sperm cells [14, 15] or keratinocytes [16, 17].
Importantly, targeting inflammation in these cells has
been shown to offer an important therapeutic poten-
tial. Thus in the context of IDD, it is important to
understand the contribution of cells like NP or annu-
lus fibrosus in regards to the inflammatory response in
order to gain a better understanding of how inflamma-
tion contributes to IDD.
The inflammasome is a multi-protein complex in which
caspase-1 is activated followed by processing of pro-
interleukin (IL)-1β and pro-IL-18 into their respective ac-
tive forms. The inflammasome has been previously
shown to play a role in infections [18–20], metabolic
syndromes [21, 22], autoimmune diseases [23–25] and
injury [11, 13, 26–28]. A positive correlation between
the degree of IDD and inflammasome content in the
disc has also been previously reported [29].
The pro-inflammatory cytokines IL-1β and tumor ne-
crosis factor (TNF) are two key cytokines that are in-
volved in the pathology of IDD [9, 30–32] and
degradation of the IVD [33, 34]. IL-1β is present in the
cell in an inactive form as pro-IL-1β, and it relies on the
inflammasome for its maturation into active IL-1β [35].
The inflammasome is a multi-protein complex com-
prised of a nod-like receptor (NLR) such as NLRP1 or
NLRP3, as well as the adaptor protein apoptosis-
associated speck-like protein containing a caspase re-
cruitment domain (CARD) (ASC), and caspase-1 [36, 37].
In addition, X-linked inhibitor of apoptosis protein (XIAP)
has been shown to maintain the inflammasome in an
inhibited state [12, 13]. The inhibitory potential of XIAP is
greatest in its full form (53 kDa) when compared to the
cleaved fragment (23 kDa).
Three receptors have been identified to play a role up-
stream of inflammasome activation (caspase-1 cleavage).
These include the pannexin-1 channel and the puriner-
gic receptors P2X4 and P2X7 [11, 38]. These receptors
rely on high extracellular potassium and adenosine tri-
phosphate (ATP) for their activation, resulting in cleav-
age of caspase-1 [36, 39, 40]. However, the exact role
that these receptors play on regulating inflammasome
activation in IDD is under investigation [41–43]. More-
over, when activated, the inflammasome is not only re-
sponsible for triggering an innate immune response, but
it is also involved in the cell death mechanism of pyrop-
tosis [37, 44] that relies on the formation of ASC oligo-
mers referred to as pyroptosomes [45].
The IVD is an avascular structure that is under con-
stant metabolic demand; as a result, the IVD is con-
stantly exposed to an environment of low oxygen, low
glucose, and high lactic acid concentrations (acidic pH
levels) [46]. It is estimated that the physiological pH
level of the IVD is around 6.8 to 7.2, whereas in the
degenerated state it can range between 6.6 and 6.3, or
even lower in cases of severe degeneration [47, 48].
Two elements of IDD are acidification of the disc en-
vironment and inflammation. Previous studies have
shown that metabolism and biosynthetic activity of disc
cells markedly decrease at acidic pH levels [49, 50]. Im-
portantly, the latter is in part mediated by the pro-
inflammatory cytokine IL-1β. Therefore, in this study,
we investigate the effects of acidification across differ-
ent pH levels on the inflammatory response produced
by human nucleus pulposus cells (HNPC) and regu-




Primary HNPC (Science Cell, Carlsbad, CA) cells were
obtained from the spinal column (isolated from the nu-
cleus pulposus of human intervertebral discs) of a male
donor that did not present spine degenerative disease.
Cells were grown in culture as a monolayer to 90 % con-
fluency. Cells were passed two to three times before use
in all experiments. HNPC were maintained in NPCM
media (Science cell, Carlsbad, CA) containing 10 ml FBS
(2 % FBS), 5 ml of NP cell growth supplement and 5 ml
of penicillin/streptomycin solution in 500 ml of NPCM
medium. Different groups of cells were grown in media
at 3 different pH levels (7.4, 6.8 and 6.5) for 24 h. NPCM
media at different pH levels were prepared by adding ei-
ther sterilized HCl (1 mol/L) or NaOH (1 mol/L). pH
levels were monitored with a Beckman 350 pH/Temp/
mV Meter. Temperature was set at 36.5 °C and 5 %
CO2. Sample size (N) presented in figure legends corre-
sponds to the number of wells that received each treat-
ment protocol.
Immunoblotting
To determine levels of inflammasome signaling proteins,
protein lysates were prepared and resolved by immuno-
blotting as described in [51]. Briefly, proteins were re-
solved in 10–20 % TGX Criterion precast gels (Bio-Rad,
Hercules, CA), transferred to polyvinylidene difluoride
membranes (Applied Biosystems, Foster City, CA) and
placed in blocking buffer for 1 h (PBS, 0.1 % Tween 20,
and 0.4 % I-Block (Applied Biosystems, Foster City,
CA)). Membranes were incubated for 1 h with primary
antibodies (1:1000) against caspase-1 (Novus Biologicals,
Littleton, CO), ASC (Santa Cruz Biotechnology, Dallas,
TX), caspase-5, (Millipore, Billerica, MA), XIAP (BD
Transduction Laboratories, San Jose, CA), IL-1β (Cell
Signaling, Billerica, MA), IL-18 (Millipore, Billerica,
MA), NLRP1 (Millipore, Billerica, MA), NLRP2 (Abcam,
Cambridge, MA), NLRP3 (Millipore, Billerica, MA),
NLRC4 (Millipore, Billerica, MA), AIM2 (eBioscience,
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San Diego, CA), pannexin-1 (Invitrogen, Carlsbad, CA),
P2X7 (Alamone Labs, Jerusalem, Israel) and P2X4
(Calbiochem, Billerica, MA). Membranes were then
washed twice for 5 min in blocking buffer and incu-
bated for 45 min with appropriate secondary horserad-
ish peroxidase (HRP)-linked antibodies (1:1000; Cell
Signaling, Billerica, MA). Proteins were visualized by
chemiluminescence with a phototope-HRP detection
kit (Cell Signaling, Billerica, MA). Band densities were
quantified with UN-SCAN-IT software, and data were
normalized to β-actin (1:5000; Sigma, St. Louis, MO).
Simple Plex assay
To determine the protein concentration of released IL-
1β and IL-18 at different pH levels, a Simple Plex assay
was run using the Ella System (Protein System) accord-
ing to manufacturer instructions. Briefly, 50 μl of diluted
sample were loaded into separate wells of the cartridge,
while 2 ml of washing buffer were loaded in the respect-
ive wells. The assay was then run by the Simple Plex
Runner Software (Protein Simple) and analyzed by the
Simple Plex Explorer (Protein Simple) based on analyte
and lot specific factory curves. Results shown corres-
pond to the mean of samples run in triplicates.
Cell viability assay
To assess cell viability of HNPC at different pH levels,
the CytoTox 96 Non-Radioactive Cytotoxicity Assay
(Promega, Madison, WI) was used according to manu-
facturer’s instructions to evaluate the number of lysed
cells. This assay measures the release of lactose de-
hydrogenase (LDH) that takes place upon cell lysis. For
this experiment, the cell media was used to run the
assay. The LDH release assay was carried after expos-
ing cells to different concentration of IL-1β human re-
combinant protein (1, 5 and 10 ng/ml, Peprotech,
Rocky Hill, NJ) for 24 h at a pH of 6.5.
siRNA silencing
ASC/pycard stealth RNAi (Invitrogen, Carlsbad, CA) was
used at a concentration of 40 nM. Cells were transfected
with stealth RNAi for 3 days and then challenged with IL-
1β human recombinant protein at a concentration of
10 ng/ml for 24 h at a pH of 6.5. The transfection protocol
consisted of treating cells with Lipofectamine 3000 trans-
fection reagent at a concentration of 40 nM according to
manufacturer instructions. Stealth siRNA/Lipofectamine
3000 duplex was diluted on serum free medium (Opti-
MEM I, Invitrogen, Carlsbad, CA).
Statistical analysis
Statistical comparisons between groups were done using
a one-way ANOVA followed by Holm-Sidak’s multiple
comparisons test or a Tukey’s multiple comparisons test.
The p-value of significance was set at p < 0.05.
Results
IL-1β and IL-18 expression in HNPC decreases at a pH of
6.5
IL-1β and IL-18 are two cytokines that rely on the
inflammasome for their activation [36, 37]. IL-1β has
been previously implicated in the pathology of IDD.
Thus, to determine the effects of pH changes on the ex-
pression of IL-1β and IL-18 in HNPC (Fig. 1a), cells
were grown in culture at a pH of 7.4 and then exposed
to a pH of 6.8 and 6.5 for 24 h. Interestingly, the protein
levels of IL-1β (Fig. 1b) and IL-18 (Fig. 1c) were de-
creased in HNPC at a pH of 6.5 when compared to a pH
of 6.8. In addition, using a Simple Plex Assay (Ella, Pro-
tein Simple) we found that the amount of released IL-18
decreased at lower pH levels when compared to 7.4
(Fig. 1d, e). These findings indicate that, as a result of
lowering the pH, the inflammatory response originating
in HNPC is decreased.
Inflammasome signaling protein expression in HNPC
decreases at a pH of 6.5
Considering the contribution of the inflammasome to
the activation of the IL-1 cytokines IL-1β and IL-18 and
the role that these cytokines play in IDD, we studied the
protein expression levels of the inflammasome proteins
caspase-1, caspase-5, ASC and XIAP (Fig. 2a). Of these
proteins, caspase-1 (Fig. 2b), ASC (Fig. 2c) and XIAP
(Fig. 2d) expression was decreased when acidification in-
creased. There was no difference in caspase-5 (another
inflammatory caspase present in humans) expression
amongst the different pH levels that were tested in this
study (Fig. 2a). These data are consistent with our find-
ings of decreased IL-1β and IL-18 expression at this pH.
NLRP1 and NLRP3 expressions in HNPC decrease at
pathological levels of pH
Inflammasomes are comprised of either a NOD-like re-
ceptor (NLR) or an AIM-2-like receptor (ALR) [36, 40].
To investigate the protein expression pattern of NLRs and
ALR at different pH levels in HNPC, we immunoblotted
for NLRP1, NLRP2, NLRP3, NLRC4 and AIM2 (Fig. 3a).
At a pH of 6.5, NLRP1 (Fig. 3b) and NLRP3 (Fig. 3c) ex-
pressions were decreased; whereas NLRP2, NLRC4 and
AIM2 protein levels were not affected (Fig. 3a).
Inflammasome signaling receptor expression in HNPC
decreases at a pH of 6. 5
We have previously identified P2X4 [11], P2X7 and
pannexin-1 [38, 52] as receptors involved in the activa-
tion of the inflammasome. To test if the expression of
these receptors is affected by different pH levels, we
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immunoblotted for these receptor proteins in lysates of
HNPC (Fig. 4a). When compared to a pH of 6.8,
pannexin-1 (Fig. 4c) was the only protein of these recep-
tors that was significantly decreased. Whereas P2X7
levels were only significantly affected when compared to
those attained at a pH of 7.4 (Fig. 4b). Whether
pannexin-1 activity is affected by this change in pH is
yet to be determined.
pH changes affect HNPC viability
The metabolic activity of HNPC has been shown to de-
crease at lower pH levels [38, 52]. In this study we show
that at a pH of 6.5, the levels of lactate dehydrogenase
(LDH) release were also decreased (Fig. 5a). Interest-
ingly, when the human IL-1β recombinant protein was
added, the levels of LDH released were increased when
compared to the untreated control group (Fig. 5b).
These findings indicate that at lower pH levels, there is
less cellular damage (less LDH released), but once IL-1β
enters the system, then there is an increase in cell death/
lysis. Moreover, exposure of HNPC to IL-1β also in-
creased the expression of ASC, a key adaptor protein in-
volved in the activation of the inflammasome (Fig. 5c).
These findings indicate that there is a decrease in cell
damage associated with lower acidity levels; however, IL-
1β exposure overrides these effects in HNPC.
Fig. 1 IL-1 cytokine expression is decreased at pathological pH. Representative immunoblot analysis of IL-1β and IL-18 at three different pH
levels (7.4, 6.8 and 6.5) (a). Densitometric analysis corresponds to the active forms of IL-1β (15 kDa, b) and IL-18 (18 kDa, c). Data presented as
mean+/−SEM. N = 6 wells per group. β-actin was used as an internal standard for protein loading control. Cell media were used to measure
protein concentration of released IL-1β (d) and IL-18 (e). Data presented as mean+/−SEM. N = 5–6 wells per group. **p < 0.05 compared to 6.8
and *p < 0.05 compared to 7.4. Data on a, b and c were obtained from lysates measured by immunoblotting, and data from d to e correspond
to supernatants measured by a Simple Plex Assay
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IL-1β contributes to the inflammatory response in HNPC
independently of the inflammasome signaling protein ASC
The basic components of the inflammasome are caspase-1
and a NOD-like receptor (NLR) protein such as NLRP1
[36, 40, 53]. ASC may or may not be present and when
present, it is thought to be an enhancer of inflammasome
activation. Moreover, ASC is a key protein involved in the
activation of the inflammasome, which can be used as a
therapeutic target against inflammation [12, 13, 54]. Since
ASC expression responds to increased levels of IL-1β
we then wanted to see the effects of IL-1β on the ex-
pression of other inflammasome proteins and whether
these changes in protein expression were dependent on
the inflammasome adaptor protein ASC. Therefore, to
determine the role of ASC on the activation of the
inflammasome, we carried out a gene silencing experi-
ment against ASC/pycard and exposed cells to 10 ng of
human IL-1β recombinant protein for 24 h. This con-
centration of IL-1β is consistent with previous studies
showing that 10 ng/ml of IL-1 contributes to the patho-
genesis of IDD [55]. Taken together, our findings
indicate that when ASC was knocked-down, the expres-
sion of the inflammasome proteins cleaved caspase-1,
NLRP1 and cleaved XIAP remained low. Interestingly,
even when the protein levels of ASC were reduced, de-
livery of IL-1β recombinant protein was able to stimu-
late the production of cleaved caspase-1, ASC, NLRP1
and cleaved XIAP (Fig. 5d and Additional file 1: Figure
S1), indicating that exogenous IL-1β has the potential
to exacerbate the inflammatory response experienced by
degenerating HNPC even in the absence of inflammasome
activation, which is consistent with the pro-inflammatory
role of IL-1β, further suggesting that exogenous IL-1β has
the potential to exacerbate the inflammatory response ex-
perienced by degenerating HNPC independent of inflam-
masome activation (Fig. 5e).
Discussion
Inflammation, a key contributor to the degeneration of
the disc, is in part mediated by IL-1β [56]. To date, how
the innate immune response regulates inflammation in
the disc remains poorly understood. In the process of
Fig. 2 Inflammasome signaling protein expression decreases at pathological pH. Representative immunoblot analysis (a) of caspase-1, caspase-5,
ASC and XIAP at three different pH levels (7.4, 6.8 and 6.5). Densitometric analysis corresponds to the active form of caspase-1 (10 kDa, b),
ASC (c) and the cleaved fragment of XIAP (23 kDa, d). β-actin was used as an internal standard for protein loading control. Data presented as
mean+/−SEM. **p < 0.05 compared to 6.8 and *p < 0.05 compared to 7.4. N = 6 wells per group
Brand et al. Journal of Inflammation  (2016) 13:29 Page 5 of 11
IDD, as the severity of degeneration increases, disc acid-
ity also increases [47, 48]. Therefore, in this study we
have tested how the inflammasome, a component of the
innate immune response, regulates IL-1β production
[48] at different pH levels.
In the process of IDD, disc cells must adjust to the
balance between catabolic and anabolic activities in
order to preserve the integrity of the extracellular
matrix of the IVD. Acidification (i.e., decrease in pH
levels) of the extracellular matrix (ECM) interferes
with protein and proteoglycan synthesis in the IVD
[50]. Accordingly, several factors contribute to the
acidification of the discs’ ECM. First, glycosaminogly-
cans (GAG) in the disc carry a high negative charge
due to the presence of carboxylate (COO−−) and sul-
fate (SO4
2−), which attract Na+, K+ and H+ ions. As a
result, the H+ concentration tends to be about 0.5
pH units lower than the surrounding serum or syn-
ovial fluid [57, 58]. Second, due to mechanical load-
ing, the disc undergoes fluid expulsion. Once the
fluid leaves the disc, the GAG concentration in-
creases, thus the H+ concentration also increases,
resulting in tissue acidification [59]. Third, the
anaerobic glycolysis that takes place in the disc re-
sults in high levels of lactate [60]. Lactate diffusion
across the disc is slow, resulting in increased acidity
in the ECM of both NP and annulus fibrosus [61];
and fourth, the disc has a Na+-H+ exchanger that
keeps the pH constant until lactate metabolism or
transport is impaired by the degenerative process
[62]. During IDD, blood supply to the disc is im-
paired, and the associated decrease in nutrient supply
leads to lower pH levels [63]. Another contributor to
the low pH levels in IDD is the production of inflam-
matory cytokines such as IL-1β and TNF, which have
been shown to increase lactate production, and as a
result, lower the pH and increase production of
matrix metalloproteinases (MMP) [46, 61, 64, 65].
An involvement of the innate immune response through
toll-like receptor (TLR) stimulation in IVD has recently
been identified. In that study lipopolysaccharide (LPS) was
used to stimulate TLR4 [66]. However, LPS is a ligand that
can activate several immune complexes in addition to
TLR4 [67], so it is possible that other TLRs may be acti-
vated in IVD. Moreover, since LPS is present during infec-
tions, further studies are needed to identify what danger/
Fig. 3 NLRP1 and NLRP3 protein expression is decreased at pathological pH. Representative immunoblot analysis (a) of NLRP1, NLRP2, NLRP3,
NLRC4 and AIM2 at three different pH levels (7.4, 6.8 and 6.5). Densitometric analysis corresponds to NLRP1 (b) and NLRP3 (c). β-actin was
used as an internal standard for protein loading control. Data presented as mean+/−SEM. **p < 0.05 compared to 6.8 and *p < 0.05 compared
to 7.4. N = 6 wells per group
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damage-associated molecular pattern activates pattern
recognition receptors such as TLRs or the NLRs that form
the inflammasome in IDD.
In addition, the NLRP3 inflammasome has been impli-
cated in the pathology of IDD. Accordingly, higher levels
of NLRP3 inflammasome proteins correlate with ad-
vanced grades of degenerated discs in humans [29]. We
have previously shown that the NLRP1 inflammasome is
active in neurons of the spinal cord after injury [13].
This neuronal NLRP1 inflammasome is comprised of
caspase-1, caspase-11 (in rodents, and caspase-5 in
humans), ASC and XIAP [13]. In the HNPC, we have
found that the expression of the inflammasome proteins
NLRP1, NLRP3, caspase-1 and ASC is decreased at a pH
of 6.5. These data further suggest that the NLRP1 and/
or NLRP3 inflammasomes are altered in the process of
IDD. Furthermore, at a decreased pH of 6.5 we have
found lower levels of cleaved XIAP, an inhibitor of the
inflammasome. The inhibitory potential of XIAP is
greatest when it is present in the full form (53 kDa)
when compared to its cleaved fragments (23 kDa). Thus
our data indicate that XIAP cleavage is decreased at
lower pH levels, indicating a higher inhibitory poten-
tial on the inflammasome at a pH of 6.5, which is
consistent with lower levels of cleaved caspase-1.
Moreover, lower levels of cleaved (active) caspase-1
are consistent with decreased processing of pro-IL-1β
(inactive) into IL-1β (active), thus signifying decreased
inflammasome-1 activity.
Moreover, in the central nervous system, inhibition of
the inflammasome by targeting the adaptor protein ASC
results in improved histopathological and functional out-
comes by decreasing inflammasome activation and IL-1β
processing [12, 13]. For this reason, we targeted ASC
using a siRNA approach and identified that, decreasing
the expression of ASC, also affected the expression of
caspase-1, cleaved XIAP and NLRP1. However, addition
of the human recombinant IL-1β protein to the system
resulted in increased expression of caspase-1 in HNPC,
suggesting that the inflammatory response experienced
by HNPC in IDD could originate in a different cell
type like annulus fibrosus cells or even dorsal root
ganglia or infiltrated inflammatory cells such as neu-
trophils. However, the effects described in this study
on inflammasome regulation in HNPC are limited to
pH changes as the insult. Therefore, the effects of
other stimuli associated with IDD such as glucose
changes or oxygen changes may contribute to the in-
crease in IL-1β that can originate in NPC and that
characterize IDD. Current studies are underway
Fig. 4 Pannexin-1 protein expression is decreased at pathological pH. Representative immunoblot analysis (a) of P2X7, P2X4 and pannexin-1
at three different pH levels (7.4, 6.8 and 6.5). Densitometric analysis corresponds to P2X7 (b) and pannexin-1 (Panx1) (c). β-actin was used as
an internal standard for protein loading control. Data presented as mean+/−SEM. **p < 0.05 compared to 6.8 and *p < 0.05 compared to 7.4.
N = 6 wells per group
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looking at inflammasome regulation as a result of these
other physiological perturbations.
Three receptors have been identified with the activa-
tion of the inflammasome. These are the purinergic re-
ceptors P2X4 and P2X7 as well as the pannexin-1
channel [11, 38, 52]. In this study, we show that
pannexin-1 expression was decreased at a pH of 6.5
when compared to 6.8 and 7.4. Pannexin-1 is involved
in the activation of the inflammasome and the pro-
cessing of IL-1β [38, 52]. Our findings showing lower
levels of pannexin-1 expression at lower pH levels are
consistent with our data indicating decreased caspase-
1/inflammasome activation and decreased processing
of IL-1β and IL-18 into their active forms. Thus,
considering previous findings on the regulation of the
inflammasome by pannexin-1, it is possible that in NP
cells, pannexin-1 may act as an upstream regulator of
the inflammasome.
We also detected a significant change in protein ex-
pression when comparing P2X7 at pH levels of 7.4 and
6.5. It is known that activation of P2X7 signaling results
in lower cytosolic pH levels by affecting the intracellular
proton balance [68, 69]. Nevertheless, extracellular acid-
ification has also been shown to inhibit P2X7 activation
[70]. In addition, extracellular ATP, which activates puri-
nergic receptors, promotes extracellular matrix biosyn-
thesis, whereas intracellular ATP promotes production
of IVD cells [71].
Fig. 5 Exogenous IL-1β contributes to the inflammatory response in HNPC. Cells were grown at 3 different pH levels (7.4, 6.8, 6.5) for 24 h
and the media was used to run a lactose dehydrogenase (LDH) release assay. Data presented as mean+/−SEM. **p < 0.05 compared to 6.8
and *p < 0.05 compared to 7.4. N = 6 wells per group (a). Cells were then grown at a pH of 6.5 and treated with human recombinant protein
to IL-1β at different concentrations (1, 5, 10 ng/ml) (b). Representative immunoblot analysis of ASC protein expression in HNPC treated with
different concentrations of IL-1β (1, 5, 10 ng/ml) for 24 h at a pH of 6.5 (c). β-actin was used as an internal standard for protein loading control. Data
presented as mean+/−SEM. *p < 0.05 compared to control. N = 6 wells per group. Silencing of ASC/pycard by siRNA in HNPC resulted in increased
caspase-1 and NLRP1 protein expression as well as increased XIAP cleavage when cells were treated with 10 ng/ml of human recombinant
IL-1β protein at a pH of 6.5. (+) indicates ASC/pycard was not silenced and (−) indicates ASC was silenced (d). Representative model of the
effects of ASC silencing and exposure to IL-1β on inflammasome activation in HNPC (e)
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In monocytes, acidic extracellular pH activates the
inflammasome by a process associated with increased
synthesis of pro-IL-1β [72]. Similarly, acidic pH changes
activate the NLRP3 inflammasome in macrophages in
response to LPS [73]. As a result, it has been suggested
that extracellular acidification acts as an alarmin that
triggers the innate immune response through the
inflammasome [73]. In contrast, it is also possible that
extracellular acidosis inhibits IL-1β-dependent innate
immune activation following stimulation of purinergic
receptors with ATP. This probably takes place as an at-
tempt to dampen an exacerbated innate immune re-
sponse [74], which is consistent with our findings
showing decreased inflammasome activation at pH
levels of 6.5. In this study, the protein expression levels
correspond to the active form of IL-1β and IL-18. For
this reason, we referred to these proteins as active.
Importantly, we have chosen pH levels considering the
normal IVD extracellular environment, and the pH level
of 6.5 that is attained during moderate to severe IDD.
Accordingly, we do expect that at even lower pH levels
(extreme degeneration, 6.3) the observed effects in this
study would be even more pronounced.
Despite increased cell viability and decreased activa-
tion of the inflammasome as well as activation of the
IL-1 cytokines IL-1β and IL-18 at a pH of 6.5, it is
well known that IL-1β is increased in degenerating
IVD. In contrast, here we show that inflammasome
activation is decreased at the lower pH of 6.5 when
compared to the physiological pH of most tissue
fluids (7.4) as well as the more acidic environment in
which IVD cells are found (6.8). The protein levels of
caspase-1, NLRP1, NLRP3, ASC and cleaved XIAP as
well as IL-1β and IL-18 were decreased at more
acidic pH levels. These data are consistent with the
findings of Razaq who showed that at lower pH, the
production of ECM proteins was inhibited, yet the
production of MMP was not decreased at lower pH
levels. Therefore, the proteins responsible for main-
taining the integrity of the disc are decreased while
the proteins responsible for degrading the disc remain
active, thus facilitating the degenerative process [48].
We suggest that at lower pH levels, the response of
NP cells is to shut down the inflammatory machinery
in order to prevent the burden of degeneration that is
associated with inflammation. However, NP cells are
still responsive to the effects of IL-1β originating
from different cell types, which results in exacerbated
inflammation. Accordingly, when we delivered IL-1β
to HNPC following silencing of ASC, HNPC showed
increased expression of caspase-1, cleaved XIAP and
the NLR protein NLRP1. It is possible that the
inflammasome in HNPC is needed to mount an in-
flammatory response in events such as infections or
when the stimulus for damage is other than pH
changes. However, here we focused on the physiology
of HNPC when only the pH is altered. Under this
scenario, when the pH is low and ASC is silenced,
then caspase-1 is not activated, yet HNPC still remain
able to respond to IL-1β from other sources, thus
HNPC are still able to produce an inflammatory re-
sponse that is ASC-independent but caspase-1-
dependent upon stimulation with IL-1β. In addition,
since ASC is considered an enhancer of the inflam-
matory response, it is possible that in the absence of
ASC the caspase-1-dependent inflammatory response
is milder than in the presence of ASC. Taken to-
gether, this would indicate that under low pH levels,
the source of IL-1β that affects NPC during degener-
ation is other than NPC themselves. Whether, the
source of inflammation is leukocytes, annulus fibrosus
cells or originating from dorsal root ganglia is under
investigation (Fig. 5e). In this regard, it has been sug-
gested that IVD cells are both the effector cells and
the target cells of the inflammatory response [75]. Ac-
cordingly, infiltration of professional inflammatory
cells into the disc seems to be a secondary inflamma-
tory event in which inflammatory cells are able to
penetrate into the disc tissue, but for this penetration
to be possible, the disc should already have signs of
degeneration. Future studies will look at the mechan-
ism of how pH changes affect inflammasome protein
expression. However, it is possible that this regulation
occurs by modulating NF-kB, a key transcriptional
regulator of inflammasome signaling. In addition, it is
important to consider that these studies were carried
on cells that were not isolated from degenerated
discs. Therefore, future studies need to focus on how
pH changes affect the inflammasome in cells obtained
from different grades of degenerated discs. However,
the different levels of pH used in this study aimed to
reflect different levels of disc degeneration.
Conclusions
The data in this study indicate that under increased
acidification conditions (6.5 pH) such as those experi-
enced during severe IDD, the main response of the NP
cells is to decrease its production of IL-1β by decreasing
inflammasome activation. Accordingly, we suggest that
the inflammation experienced by the NP originates ei-
ther from the annulus fibrosus or from infiltrated cells
such as leukocytes, or even the dorsal root ganglia,
which we are investigating at this time. However, other
stimuli besides increased acidification, like altered oxy-
genation or altered glucose levels, may also be the trig-
gers for the increased IL-1β levels that are found in the
NP during IDD.
Brand et al. Journal of Inflammation  (2016) 13:29 Page 9 of 11
Additional file
Additional file 1: Figure S1. Immunoblot of ASC following gene
silencing procedures for ASC using siRNA (si) against ASC as well as the
scrambled siRNA control (scr), indicating that the scrambled control did
not affect ASC expression. (JPG 110 kb)
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